Cardiothoracic & vascular anesthesia

Impact of Priming Volume Reduction on Hematocrit Retention in Pediatric Cardiopulmonary Bypass: A Retrospective Analysis

Paediatr AnaesthPublished Retrospective cohort study

Authors' conclusion

These findings suggest that even partial retrograde autologous priming is effective to mitigate hemodilution and is independently associated with improved hematocrit retention and a significant reduction in transfusion risk after initiation of cardiopulmonary bypass in pediatric patients.

Study context

Population
Patients aged 0–14 years, weight > 6 kg, undergoing repair of ventricular and/or atrial septal defects with CPB
Participants
191 patients
Exposure
Retrograde autologous priming vs control
  • Retrograde autologous primingn = 144
  • Controln = 47reference
Outcome
Correlation between priming volume reduction rate (proportion of priming solution replaced) and hematocrit retention ratio (hematocrit immediately after CPB initiation / pre-bypass hematocrit)

Main finding

As reported in the abstract

Priming volume reduction rate vs hematocrit retention ratio

Spearman's ρ (positive correlation), p < 0.001

0.545

Multiple regression: 0.1 increase in priming volume reduction rate → absolute increase in hematocrit at bypass initiation (independent association)

0.5%

Observational data: associations, not effects.

Secondary outcomes

Transfusion-free surgery

relative risk ratio 1.22 · P = 0.005

ICU and hospital LOS

No significant difference between groups

Safety

Regional cerebral oxygen saturation trends and lactate levels

No significant intergroup differences (Time × retrograde autologous priming interaction); no evidence of cerebral perfusion suppression

Original publication

Impact of Priming Volume Reduction on Hematocrit Retention in Pediatric Cardiopulmonary Bypass: A Retrospective Analysis. Paediatr Anaesth. Published 24 March 2026. doi:10.1002/pan.70173

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.